Massachusetts Proposes Installment Plan to Cover Cost of Gene Therapy for Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is a genetic condition which affects between 10,000 and 25,000 in the United States. While rare, it is currently the leading genetic cause of infant mortality. But,…

Continue Reading Massachusetts Proposes Installment Plan to Cover Cost of Gene Therapy for Spinal Muscular Atrophy

First Patient Dosed in Phase 1b Trial Aiming to Inhibit the Progression of Nonalcoholic Steatohepatitis

Nonalcoholic fatty liver disease (NAFLD) is a condition which causes fat to accumulate in the liver. Nonalcoholic steatohepatitis (NASH) is a severe form of the disease in which the patient also…

Continue Reading First Patient Dosed in Phase 1b Trial Aiming to Inhibit the Progression of Nonalcoholic Steatohepatitis

Funds Raised For Researching Mucopolysaccharidosis and Other Rare Diseases

Xconomy.com has just released that funds have been raised for a variety of companies investigating therapies for rare conditions. Unfortunately, novel therapies and inventions cost million of dollars to develop. Thankfully,…

Continue Reading Funds Raised For Researching Mucopolysaccharidosis and Other Rare Diseases
A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!
source: pixabay.com

A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!

Myelodysplastic syndromes (MDS) is the name used to describe a group of stem cell disorders in which the body can't produce an adequate amount of platelets and blood cells. Currently,…

Continue Reading A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!

Australian Government Initiates New Trial Program to Support Individuals Recently Diagnosed with a Rare Disease

Being diagnosed with any serious condition can be scary, overwhelming, and full of unknowns. For those who are diagnosed with a rare disease such as Duchenne muscular dystrophy, spinal muscular atrophy,…

Continue Reading Australian Government Initiates New Trial Program to Support Individuals Recently Diagnosed with a Rare Disease

A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

Each year the Food and Drug Administration approves dozens of new therapies to fulfill unmet needs for various patient populations. It's just been published that in 2018 they approved a…

Continue Reading A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

Positive Results for aTTP Announced by New England Journal of Medicine

Patients with acquired thrombotic thrombocytopenic purpura (aTTP) showed a significantly improved platelet count response after treatment with Cablivi® according to the New England Journal of Medicine's Phase 3 trial results. A…

Continue Reading Positive Results for aTTP Announced by New England Journal of Medicine

New Technology for Diagnosing Rare Conditions by Photograph May Foster Employment Discrimination?

As discussed in a recent article on PatientWorthy the FDNA has recently developed a new kind of algorithm which can diagnose rare genetic conditions such as Angelman syndrome, Williams syndrome, and Fragile X syndrome using…

Continue Reading New Technology for Diagnosing Rare Conditions by Photograph May Foster Employment Discrimination?

National Geographic Features Innovative Research That Will Advance Precision Medicine

Perhaps the most difficult thing about rare disease research is that not only do the conditions affect only a small portion of the population, but like every diagnosis, they affect…

Continue Reading National Geographic Features Innovative Research That Will Advance Precision Medicine

New Discovery Could Lead to New Treatments for Anemia in Juvenile Idiopathic Arthritis, Lupus, and Malaria

Juvenile idiopathic arthritis, Lupus, and Malaria are diseases which currently have limited treatment options. But a new discovery by researchers at the Benaroya Research Institute (BRI) could potentially lead to…

Continue Reading New Discovery Could Lead to New Treatments for Anemia in Juvenile Idiopathic Arthritis, Lupus, and Malaria
New Combination Therapy for Renal Cell Carcinoma Gains European Approval
source: pixabay.com

New Combination Therapy for Renal Cell Carcinoma Gains European Approval

According to a story from BioPortfolio, the Bristol-Myers Squibb Company recently announced that the European Commission has recently approved the first combination treatment for renal cell carcinoma available in the…

Continue Reading New Combination Therapy for Renal Cell Carcinoma Gains European Approval
Researchers Pioneer Method to Reverse IPEX Syndrome Mutation
mohamed_hassan / Pixabay

Researchers Pioneer Method to Reverse IPEX Syndrome Mutation

According to a story from news-medical.net, a team of researchers from UCLA have successfully developed an approach that allows for the reversal of the mutation that is responsible for the…

Continue Reading Researchers Pioneer Method to Reverse IPEX Syndrome Mutation